BI
Bio-Rad Laboratories, Inc.
BIO-B · NYSE
$385.84 +5.69% (+$20.76)
1M -0.56%
Market Cap $9.83B
P/E Ratio 44.18x
Div. Yield -
ROE 3.15%
Bulios Fair Price
$326.6
15.4% downside
Trenutna cena
$385.84
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica BIO-B trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
37 /100
Fair P/E 44.18x
EV/EBITDA 19.67x
P/S 3.80x
Growth
41 /100
Stable Rev. growth 6.63%
FCF growth 39.32%
Book val. growth 18.66%
Profitability
68 /100
Strong Gross margin 51.90%
Net margin 8.59%
Op. margin 9.08%
Quality
12 /100
Poor ROIC 1.54%
ROE 3.15%
ROA 2.17%
Debt
91 /100
Low Debt/Equity 0.17x
Current ratio 3.14x
Int. coverage 10.55x
Stability
47 /100
Moderate Beta 1.11x
Rev. volatility 9.85%
EPS volatility 153.89%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BIO-B
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Norman D. Schwartz
Employees
7,450
Headquarters
Hercules
Prihajajoči dogodki
22 OKT.
Earnings
Upcoming earnings report